NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS
Publication
, Conference
Khasraw, M; McDonald, K; Yip, S; Verhaak, RG; Heimberger, AB; Hall, M; Barnes, E; Hovey, E; Ellingson, BM; Lwin, Z
Published in: NEURO-ONCOLOGY
September 1, 2018
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
September 1, 2018
Volume
20
Start / End Page
236 / 236
Location
Stockholm, SWEDEN
Publisher
OXFORD UNIV PRESS INC
Conference Name
13th Meeting of the European-Association-of-Neurooncology (EANO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., McDonald, K., Yip, S., Verhaak, R. G., Heimberger, A. B., Hall, M., … Lwin, Z. (2018). NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS. In NEURO-ONCOLOGY (Vol. 20, pp. 236–236). Stockholm, SWEDEN: OXFORD UNIV PRESS INC.
Khasraw, M., K. McDonald, S. Yip, R. G. Verhaak, A. B. Heimberger, M. Hall, E. Barnes, E. Hovey, B. M. Ellingson, and Z. Lwin. “NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS.” In NEURO-ONCOLOGY, 20:236–236. OXFORD UNIV PRESS INC, 2018.
Khasraw M, McDonald K, Yip S, Verhaak RG, Heimberger AB, Hall M, et al. NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 236–236.
Khasraw, M., et al. “NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS.” NEURO-ONCOLOGY, vol. 20, OXFORD UNIV PRESS INC, 2018, pp. 236–236.
Khasraw M, McDonald K, Yip S, Verhaak RG, Heimberger AB, Hall M, Barnes E, Hovey E, Ellingson BM, Lwin Z. NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2018. p. 236–236.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
September 1, 2018
Volume
20
Start / End Page
236 / 236
Location
Stockholm, SWEDEN
Publisher
OXFORD UNIV PRESS INC
Conference Name
13th Meeting of the European-Association-of-Neurooncology (EANO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences